Burd A, Levine RL, Shoben A, et al. Initial Report of the Beat AML Umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies. ASH Annual Meeting and Exposition 2018, abstract 559.
Isatuximab, carfilzomib en dexamethason bij gerecidiveerd multipel myeloom (IKEMA)
aug 2021 | MM